Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
23
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Quartel Adrian W | Chief Medical Officer | 2 | $0 | $0 | 2026-07-27 |
| Szwarcberg Javier B. | Chief Executive Officer | 43 | $0 | $0 | 2026-06-30 |
| Walbert Keli | Director | 2 | $0 | $0 | 2026-05-21 |
| Barretto-Ko Percival | Director | 6 | $0 | $0 | 2026-05-21 |
| SIMPSON CAMILLA V | Director | 22 | $0 | $231.8K | 2026-05-21 |
| GREY MICHAEL G | Executive Chairman | 19 | $0 | $0 | 2026-05-21 |
| SPIEGELMAN DANIEL K | Director | 12 | $0 | $0 | 2026-05-21 |
| Hooks Corwin Dale | Chief Commercial Officer | 1 | $0 | $0 | 2026-03-09 |
| Gharib Samir M. | President & CFO | 65 | $0 | $0 | 2025-12-15 |
| Ways Kirk | Interim Chief Medical Officer | 12 | $0 | $0 | 2025-12-11 |
| Parkman Healthcare Partners LLC | 10% Owner | 6 | $9.2K | $9.8K | 2025-10-06 |
| Muralidhar Bali | Director | 8 | $3.00M | $0 | 2025-07-22 |
| Aynechi Tiba | Director | 4 | $0 | $0 | 2025-07-22 |
| Charlton Ralph William III | Chief Medical Officer | 19 | $0 | $0 | 2024-12-16 |
| Novo Holdings A/S | 10% Owner | 12 | $10.75M | $10.02M | 2024-03-21 |
| O'Donnell Niall | Director | 8 | $5.75M | $0 | 2023-05-25 |
| Chaya Moghrabi Dina | Director | 5 | $3.75M | $0 | 2022-05-25 |
| Dias Subaweerage | Chief Medical Officer | 3 | $0 | $0 | 2021-12-16 |
| KING RICHARD | Chief Executive Officer | 2 | $0 | $0 | 2021-06-30 |
| Omega Fund VI GP Manager, Ltd. | 10% Owner | 3 | $3.75M | $0 | 2020-10-14 |
| HANSSON JONAS | Director | 3 | $3.75M | $0 | 2020-10-14 |
| HealthCap VIII, L.P. | Other | 3 | $3.75M | $0 | 2020-10-14 |
| RiverVest Venture Fund III, L.P. | 10% Owner | 5 | $3.75M | $0 | 2020-10-14 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Quartel Adrian W | Chief Medical Officer | A Award deriv | 2026-07-27 | 2026-07-29 | 13,000 | — | $0 | 13,000 | SEC↗ |
| Quartel Adrian W | Chief Medical Officer | A Award deriv | 2026-07-27 | 2026-07-29 | 13,000 | — | $0 | 13,000 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | A Award | 2026-06-30 | 2026-07-09 | 266 | $4.53 | $1.2K | 19,270 | SEC↗ |
| Barretto-Ko Percival | Director | A Award deriv | 2026-05-21 | 2026-05-26 | 1,700 | — | $0 | 1,700 | SEC↗ |
| GREY MICHAEL G | Executive Chairman | A Award deriv | 2026-05-21 | 2026-05-26 | 1,700 | — | $0 | 1,700 | SEC↗ |
| SIMPSON CAMILLA V | Director | A Award deriv | 2026-05-21 | 2026-05-26 | 1,700 | — | $0 | 1,700 | SEC↗ |
| SPIEGELMAN DANIEL K | Director | A Award deriv | 2026-05-21 | 2026-05-26 | 1,700 | — | $0 | 1,700 | SEC↗ |
| Walbert Keli | Director | A Award deriv | 2026-05-21 | 2026-05-26 | 1,700 | — | $0 | 1,700 | SEC↗ |
| Hooks Corwin Dale | Chief Commercial Officer | A Award deriv | 2026-03-09 | 2026-03-09 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | A Award | 2025-12-31 | 2026-01-05 | 4,690 | $4.53 | $21.2K | 19,004 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2025-12-15 | 2025-12-17 | 1,196 | — | $0 | 2,392 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2025-12-15 | 2025-12-17 | 1,480 | — | $0 | 1,480 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | M Exercise deriv | 2025-12-15 | 2025-12-17 | 496 | — | $0 | 497 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | M Exercise deriv | 2025-12-15 | 2025-12-17 | 513 | — | $0 | 1,027 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | M Exercise | 2025-12-15 | 2025-12-17 | 1,196 | — | $0 | 14,922 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | M Exercise | 2025-12-15 | 2025-12-17 | 1,480 | — | $0 | 14,478 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | F Tax w/h | 2025-12-15 | 2025-12-17 | 608 | $80.67 | $49.0K | 14,314 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | F Tax w/h | 2025-12-15 | 2025-12-17 | 752 | $80.67 | $60.7K | 13,726 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | F Tax w/h | 2025-12-15 | 2025-12-17 | 184 | $80.67 | $14.8K | 8,263 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | M Exercise | 2025-12-15 | 2025-12-17 | 513 | — | $0 | 8,447 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | F Tax w/h | 2025-12-15 | 2025-12-17 | 178 | $80.67 | $14.4K | 7,934 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | M Exercise | 2025-12-15 | 2025-12-17 | 496 | — | $0 | 8,112 | SEC↗ |
| Ways Douglas Kirk | Interim Chief Medical Office | D To issuer deriv | 2025-12-11 | 2026-01-21 | 400 | — | $0 | 0 | SEC↗ |
| Ways Douglas Kirk | Interim Chief Medical Office | A Award deriv | 2025-12-11 | 2026-01-21 | 400 | — | $0 | 400 | SEC↗ |
| Ways Douglas Kirk | Interim Chief Medical Office | D To issuer deriv | 2025-12-11 | 2026-01-21 | 266 | — | $0 | 0 | SEC↗ |
| Ways Douglas Kirk | Interim Chief Medical Office | A Award deriv | 2025-12-11 | 2026-01-21 | 266 | — | $0 | 266 | SEC↗ |
| Ways Douglas Kirk | Interim Chief Medical Office | A Award deriv | 2025-12-11 | 2026-01-21 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Ways Douglas Kirk | Interim Chief Medical Office | M Exercise deriv | 2025-12-11 | 2026-01-21 | 1,250 | — | $0 | 3,750 | SEC↗ |
| Ways Douglas Kirk | Interim Chief Medical Office | M Exercise | 2025-12-11 | 2026-01-21 | 1,250 | — | $0 | 1,250 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2025-12-11 | 2025-12-12 | 4,950 | — | $0 | 14,850 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | A Award deriv | 2025-12-11 | 2025-12-12 | 19,800 | — | $0 | 19,800 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | A Award deriv | 2025-12-11 | 2025-12-12 | 7,600 | — | $0 | 7,600 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | M Exercise deriv | 2025-12-11 | 2025-12-12 | 1,900 | — | $0 | 5,700 | SEC↗ |
| Walbert Keli | Director | A Award deriv | 2025-12-11 | 2025-12-15 | 3,400 | — | $0 | 3,400 | SEC↗ |
| Barretto-Ko Percival | Director | A Award deriv | 2025-12-11 | 2025-12-15 | 800 | — | $0 | 800 | SEC↗ |
| Barretto-Ko Percival | Director | D To issuer deriv | 2025-12-11 | 2025-12-15 | 800 | — | $0 | 0 | SEC↗ |
| SIMPSON CAMILLA V | Director | A Award deriv | 2025-12-11 | 2025-12-15 | 362 | — | $0 | 362 | SEC↗ |
| SIMPSON CAMILLA V | Director | A Award deriv | 2025-12-11 | 2025-12-15 | 400 | — | $0 | 400 | SEC↗ |
| SIMPSON CAMILLA V | Director | D To issuer deriv | 2025-12-11 | 2025-12-15 | 133 | — | $0 | 0 | SEC↗ |
| SIMPSON CAMILLA V | Director | A Award deriv | 2025-12-11 | 2025-12-15 | 133 | — | $0 | 133 | SEC↗ |
| SIMPSON CAMILLA V | Director | D To issuer deriv | 2025-12-11 | 2025-12-15 | 362 | — | $0 | 0 | SEC↗ |
| SIMPSON CAMILLA V | Director | D To issuer deriv | 2025-12-11 | 2025-12-15 | 400 | — | $0 | 0 | SEC↗ |
| SIMPSON CAMILLA V | Director | D To issuer deriv | 2025-12-11 | 2025-12-15 | 309 | — | $0 | 0 | SEC↗ |
| SIMPSON CAMILLA V | Director | A Award deriv | 2025-12-11 | 2025-12-15 | 309 | — | $0 | 309 | SEC↗ |
| SIMPSON CAMILLA V | Director | D To issuer deriv | 2025-12-11 | 2025-12-15 | 173 | — | $0 | 0 | SEC↗ |
| SIMPSON CAMILLA V | Director | A Award deriv | 2025-12-11 | 2025-12-15 | 173 | — | $0 | 173 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | D To issuer deriv | 2025-12-11 | 2025-12-15 | 10,000 | — | $0 | 0 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | A Award deriv | 2025-12-11 | 2025-12-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | A Award deriv | 2025-12-11 | 2025-12-15 | 733 | — | $0 | 733 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | A Award deriv | 2025-12-11 | 2025-12-15 | 933 | — | $0 | 933 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | D To issuer deriv | 2025-12-11 | 2025-12-15 | 1,933 | — | $0 | 0 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | A Award deriv | 2025-12-11 | 2025-12-15 | 1,933 | — | $0 | 1,933 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | D To issuer deriv | 2025-12-11 | 2025-12-15 | 733 | — | $0 | 0 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | D To issuer deriv | 2025-12-11 | 2025-12-15 | 933 | — | $0 | 0 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | D To issuer deriv | 2025-12-11 | 2025-12-15 | 953 | — | $0 | 0 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | A Award deriv | 2025-12-11 | 2025-12-15 | 953 | — | $0 | 953 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | D To issuer deriv | 2025-12-11 | 2025-12-15 | 1,579 | — | $0 | 0 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | A Award deriv | 2025-12-11 | 2025-12-15 | 1,579 | — | $0 | 1,579 | SEC↗ |
| GREY MICHAEL G | Executive Chairman | A Award deriv | 2025-12-11 | 2025-12-15 | 666 | — | $0 | 666 | SEC↗ |
| GREY MICHAEL G | Executive Chairman | D To issuer deriv | 2025-12-11 | 2025-12-15 | 133 | — | $0 | 0 | SEC↗ |
| GREY MICHAEL G | Executive Chairman | A Award deriv | 2025-12-11 | 2025-12-15 | 133 | — | $0 | 133 | SEC↗ |
| GREY MICHAEL G | Executive Chairman | D To issuer deriv | 2025-12-11 | 2025-12-15 | 1,499 | — | $0 | 0 | SEC↗ |
| GREY MICHAEL G | Executive Chairman | A Award deriv | 2025-12-11 | 2025-12-15 | 1,499 | — | $0 | 1,499 | SEC↗ |
| GREY MICHAEL G | Executive Chairman | D To issuer deriv | 2025-12-11 | 2025-12-15 | 1,255 | — | $0 | 0 | SEC↗ |
| GREY MICHAEL G | Executive Chairman | A Award deriv | 2025-12-11 | 2025-12-15 | 1,255 | — | $0 | 1,255 | SEC↗ |
| GREY MICHAEL G | Executive Chairman | D To issuer deriv | 2025-12-11 | 2025-12-15 | 387 | — | $0 | 0 | SEC↗ |
| GREY MICHAEL G | Executive Chairman | A Award deriv | 2025-12-11 | 2025-12-15 | 387 | — | $0 | 387 | SEC↗ |
| GREY MICHAEL G | Executive Chairman | D To issuer deriv | 2025-12-11 | 2025-12-15 | 400 | — | $0 | 0 | SEC↗ |
| GREY MICHAEL G | Executive Chairman | A Award deriv | 2025-12-11 | 2025-12-15 | 400 | — | $0 | 400 | SEC↗ |
| GREY MICHAEL G | Executive Chairman | D To issuer deriv | 2025-12-11 | 2025-12-15 | 666 | — | $0 | 0 | SEC↗ |
| SPIEGELMAN DANIEL K | Director | D To issuer deriv | 2025-12-11 | 2025-12-15 | 400 | — | $0 | 0 | SEC↗ |
| SPIEGELMAN DANIEL K | Director | D To issuer deriv | 2025-12-11 | 2025-12-15 | 458 | — | $0 | 0 | SEC↗ |
| SPIEGELMAN DANIEL K | Director | A Award deriv | 2025-12-11 | 2025-12-15 | 458 | — | $0 | 458 | SEC↗ |
| SPIEGELMAN DANIEL K | Director | A Award deriv | 2025-12-11 | 2025-12-15 | 88 | — | $0 | 88 | SEC↗ |
| SPIEGELMAN DANIEL K | Director | A Award deriv | 2025-12-11 | 2025-12-15 | 400 | — | $0 | 400 | SEC↗ |
| SPIEGELMAN DANIEL K | Director | D To issuer deriv | 2025-12-11 | 2025-12-15 | 88 | — | $0 | 0 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | D To issuer deriv | 2025-12-11 | 2025-12-17 | 1,666 | — | $0 | 0 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | A Award deriv | 2025-12-11 | 2025-12-17 | 1,666 | — | $0 | 1,666 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | M Exercise | 2025-12-11 | 2025-12-12 | 4,950 | — | $0 | 15,192 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | F Tax w/h | 2025-12-11 | 2025-12-12 | 2,194 | $88.41 | $194.0K | 12,998 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | F Tax w/h | 2025-12-11 | 2025-12-12 | 680 | $88.41 | $60.1K | 7,616 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | M Exercise | 2025-12-11 | 2025-12-12 | 1,900 | — | $0 | 8,296 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2025-12-10 | 2025-12-12 | 1,196 | — | $0 | 3,588 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | M Exercise deriv | 2025-12-10 | 2025-12-12 | 514 | — | $0 | 1,539 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | M Exercise | 2025-12-10 | 2025-12-12 | 1,196 | — | $0 | 10,670 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | F Tax w/h | 2025-12-10 | 2025-12-12 | 428 | $85.67 | $36.7K | 10,242 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | F Tax w/h | 2025-12-10 | 2025-12-12 | 184 | $85.67 | $15.8K | 6,396 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | M Exercise | 2025-12-10 | 2025-12-12 | 514 | — | $0 | 6,580 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | A Award deriv | 2025-10-20 | 2025-10-22 | 4,784 | — | $0 | 4,784 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2025-10-20 | 2025-10-22 | 4,784 | — | $0 | 0 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | M Exercise deriv | 2025-10-20 | 2025-10-22 | 2,053 | — | $0 | 0 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | A Award deriv | 2025-10-20 | 2025-10-22 | 2,053 | — | $0 | 2,053 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | F Tax w/h | 2025-10-20 | 2025-10-22 | 1,539 | $148.16 | $228.0K | 9,474 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | M Exercise | 2025-10-20 | 2025-10-22 | 4,784 | — | $0 | 11,013 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | F Tax w/h | 2025-10-20 | 2025-10-22 | 661 | $148.16 | $97.9K | 6,066 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | M Exercise | 2025-10-20 | 2025-10-22 | 2,053 | — | $0 | 6,727 | SEC↗ |
| Parkman Healthcare Partners LL | 10% Owner | P Buy | 2025-10-06 | 2025-10-08 | 256 | $17.91 | $4.6K | 1,307 | SEC↗ |
| Parkman Healthcare Partners LL | 10% Owner | S Sale | 2025-10-06 | 2025-10-08 | 25 | $17.46 | $437 | 1,050 | SEC↗ |
| Parkman Healthcare Partners LL | 10% Owner | S Sale | 2025-10-06 | 2025-10-08 | 232 | $19.33 | $4.5K | 1,075 | SEC↗ |
| Parkman Healthcare Partners LL | 10% Owner | S Sale | 2025-10-06 | 2025-10-15 | 25 | $17.46 | $437 | 1,050 | SEC↗ |
| Parkman Healthcare Partners LL | 10% Owner | P Buy | 2025-10-06 | 2025-10-15 | 256 | $17.91 | $4.6K | 1,307 | SEC↗ |
| Parkman Healthcare Partners LL | 10% Owner | S Sale | 2025-10-06 | 2025-10-15 | 232 | $19.33 | $4.5K | 1,075 | SEC↗ |
| Ways Kirk | Interim Chief Medical Office | A Award deriv | 2025-07-23 | 2025-07-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Muralidhar Bali | Director | A Award deriv | 2025-07-22 | 2025-07-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Aynechi Tiba | Director | A Award deriv | 2025-07-22 | 2025-07-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Barretto-Ko Percival | Director | A Award deriv | 2025-07-22 | 2025-07-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| GREY MICHAEL G | Executive Chairman | A Award deriv | 2025-07-22 | 2025-07-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SIMPSON CAMILLA V | Director | A Award deriv | 2025-07-22 | 2025-07-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SPIEGELMAN DANIEL K | Director | A Award deriv | 2025-07-22 | 2025-07-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2024-12-16 | 2024-12-20 | 89,700 | — | $0 | 269,100 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2024-12-16 | 2024-12-20 | 111,000 | — | $0 | 222,000 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | M Exercise deriv | 2024-12-16 | 2024-12-20 | 37,250 | — | $0 | 74,500 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | M Exercise deriv | 2024-12-16 | 2024-12-20 | 38,500 | — | $0 | 115,500 | SEC↗ |
| Charlton Ralph William III | CHIEF MEDICAL OFFICER | M Exercise deriv | 2024-12-16 | 2024-12-20 | 26,600 | — | $0 | 79,800 | SEC↗ |
| Charlton Ralph William III | CHIEF MEDICAL OFFICER | M Exercise deriv | 2024-12-16 | 2024-12-20 | 31,750 | — | $0 | 63,500 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | M Exercise | 2024-12-16 | 2024-12-20 | 89,700 | — | $0 | 427,801 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | F Tax w/h | 2024-12-16 | 2024-12-20 | 32,005 | $0.39 | $12.5K | 395,796 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | M Exercise | 2024-12-16 | 2024-12-20 | 111,000 | — | $0 | 506,796 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | F Tax w/h | 2024-12-16 | 2024-12-20 | 39,605 | $0.39 | $15.4K | 467,191 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | F Tax w/h | 2024-12-16 | 2024-12-20 | 13,291 | $0.39 | $5.2K | 350,550 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | M Exercise | 2024-12-16 | 2024-12-20 | 38,500 | — | $0 | 340,328 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | M Exercise | 2024-12-16 | 2024-12-20 | 37,250 | — | $0 | 363,841 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | F Tax w/h | 2024-12-16 | 2024-12-20 | 13,737 | $0.39 | $5.4K | 326,591 | SEC↗ |
| Charlton Ralph William III | CHIEF MEDICAL OFFICER | M Exercise | 2024-12-16 | 2024-12-20 | 26,600 | — | $0 | 150,409 | SEC↗ |
| Charlton Ralph William III | CHIEF MEDICAL OFFICER | M Exercise | 2024-12-16 | 2024-12-20 | 31,750 | — | $0 | 172,668 | SEC↗ |
| Charlton Ralph William III | CHIEF MEDICAL OFFICER | F Tax w/h | 2024-12-16 | 2024-12-20 | 9,491 | $0.39 | $3.7K | 140,918 | SEC↗ |
| Charlton Ralph William III | CHIEF MEDICAL OFFICER | F Tax w/h | 2024-12-16 | 2024-12-20 | 11,329 | $0.39 | $4.4K | 161,339 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2024-12-10 | 2024-12-20 | 358,800 | — | $0 | 358,800 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | M Exercise deriv | 2024-12-10 | 2024-12-20 | 154,000 | — | $0 | 154,000 | SEC↗ |
| Charlton Ralph William III | CHIEF MEDICAL OFFICER | M Exercise deriv | 2024-12-10 | 2024-12-20 | 106,400 | — | $0 | 106,400 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | F Tax w/h | 2024-12-10 | 2024-12-20 | 128,020 | $0.54 | $69.1K | 338,101 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | M Exercise | 2024-12-10 | 2024-12-20 | 358,800 | — | $0 | 466,121 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | M Exercise | 2024-12-10 | 2024-12-20 | 154,000 | — | $0 | 356,776 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | F Tax w/h | 2024-12-10 | 2024-12-20 | 54,948 | $0.54 | $29.7K | 301,828 | SEC↗ |
| Charlton Ralph William III | CHIEF MEDICAL OFFICER | M Exercise | 2024-12-10 | 2024-12-20 | 106,400 | — | $0 | 161,773 | SEC↗ |
| Charlton Ralph William III | CHIEF MEDICAL OFFICER | F Tax w/h | 2024-12-10 | 2024-12-20 | 37,964 | $0.54 | $20.5K | 123,809 | SEC↗ |
| Aynechi Tiba | Director | A Award deriv | 2024-05-22 | 2024-05-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Barretto-Ko Percival | Director | A Award deriv | 2024-05-22 | 2024-05-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| GREY MICHAEL G | Executive Chairman | A Award deriv | 2024-05-22 | 2024-05-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Muralidhar Bali | Director | A Award deriv | 2024-05-22 | 2024-05-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SIMPSON CAMILLA V | Director | A Award deriv | 2024-05-22 | 2024-05-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SPIEGELMAN DANIEL K | Director | A Award deriv | 2024-05-22 | 2024-05-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Ways Kirk | Director | A Award deriv | 2024-05-22 | 2024-05-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Novo Holdings A/S | 10% Owner | S Sale | 2024-03-21 | 2024-03-25 | 465,021 | $0.75 | $348.8K | 2,550,000 | SEC↗ |
| Novo Holdings A/S | 10% Owner | S Sale | 2024-03-20 | 2024-03-20 | 359,979 | $0.73 | $262.8K | 3,015,021 | SEC↗ |
| Novo Holdings A/S | 10% Owner | S Sale | 2024-03-19 | 2024-03-20 | 593,000 | $0.76 | $450.7K | 3,375,000 | SEC↗ |
| Novo Holdings A/S | 10% Owner | S Sale | 2024-03-18 | 2024-03-20 | 842,020 | $0.77 | $648.4K | 3,968,000 | SEC↗ |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | A Award deriv | 2024-03-14 | 2024-03-18 | 358,800 | — | $0 | 358,800 | SEC↗ |
| Gharib Samir M. | PRESIDENT AND CFO | A Award deriv | 2024-03-14 | 2024-03-18 | 154,000 | — | $0 | 154,000 | SEC↗ |
| Charlton Ralph William III | CHIEF MEDICAL OFFICER | A Award deriv | 2024-03-14 | 2024-03-18 | 106,400 | — | $0 | 106,400 | SEC↗ |
| Novo Holdings A/S | 10% Owner | S Sale | 2024-03-14 | 2024-03-18 | 1,912,316 | $0.89 | $1.70M | 4,810,020 | SEC↗ |
| Gharib Samir M. | President & CFO | A Award | 2023-12-29 | 2024-01-03 | 11,255 | $0.98 | $11.0K | 202,776 | SEC↗ |
| Charlton Ralph William III | Chief Medical Officer | A Award | 2023-12-29 | 2024-01-03 | 9,361 | $0.98 | $9.2K | 55,373 | SEC↗ |
| Szwarcberg Javier B. | Chief Executive Officer | M Exercise deriv | 2023-12-15 | 2023-12-18 | 111,000 | — | $0 | 333,000 | SEC↗ |
| Gharib Samir M. | President & CFO | M Exercise deriv | 2023-12-15 | 2023-12-18 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Gharib Samir M. | President & CFO | M Exercise deriv | 2023-12-15 | 2023-12-18 | 37,250 | — | $0 | 111,750 | SEC↗ |
| Charlton Ralph William III | Chief Medical Officer | M Exercise deriv | 2023-12-15 | 2023-12-18 | 31,750 | — | $0 | 95,250 | SEC↗ |
| Szwarcberg Javier B. | Chief Executive Officer | M Exercise | 2023-12-15 | 2023-12-18 | 111,000 | — | $0 | 145,705 | SEC↗ |
| Szwarcberg Javier B. | Chief Executive Officer | F Tax w/h | 2023-12-15 | 2023-12-18 | 38,384 | $1.66 | $63.7K | 107,321 | SEC↗ |
| Gharib Samir M. | President & CFO | F Tax w/h | 2023-12-15 | 2023-12-18 | 23,213 | $1.66 | $38.5K | 167,153 | SEC↗ |
| Gharib Samir M. | President & CFO | M Exercise | 2023-12-15 | 2023-12-18 | 75,000 | — | $0 | 190,366 | SEC↗ |
| Gharib Samir M. | President & CFO | M Exercise | 2023-12-15 | 2023-12-18 | 37,250 | — | $0 | 204,403 | SEC↗ |
| Gharib Samir M. | President & CFO | F Tax w/h | 2023-12-15 | 2023-12-18 | 12,882 | $1.66 | $21.4K | 191,521 | SEC↗ |
| Charlton Ralph William III | Chief Medical Officer | M Exercise | 2023-12-15 | 2023-12-18 | 31,750 | — | $0 | 56,992 | SEC↗ |
| Charlton Ralph William III | Chief Medical Officer | F Tax w/h | 2023-12-15 | 2023-12-18 | 10,980 | $1.66 | $18.2K | 46,012 | SEC↗ |
| Szwarcberg Javier B. | Chief Executive Officer | A Award deriv | 2023-12-14 | 2023-12-18 | 717,600 | — | $0 | 717,600 | SEC↗ |
| Gharib Samir M. | President & CFO | A Award deriv | 2023-12-14 | 2023-12-18 | 308,000 | — | $0 | 308,000 | SEC↗ |
| Charlton Ralph William III | Chief Medical Officer | A Award deriv | 2023-12-14 | 2023-12-18 | 212,800 | — | $0 | 212,800 | SEC↗ |
| Szwarcberg Javier B. | Chief Executive Officer | A Award deriv | 2023-11-26 | 2023-11-28 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Gharib Samir M. | President & CFO | A Award deriv | 2023-11-08 | 2023-11-13 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Gharib Samir M. | President & CFO | M Exercise deriv | 2023-06-30 | 2023-07-05 | 75,000 | — | $0 | 150,000 | SEC↗ |
| Gharib Samir M. | President & CFO | A Award | 2023-06-30 | 2023-07-05 | 10,484 | $0.98 | $10.3K | 66,302 | SEC↗ |
| Gharib Samir M. | President & CFO | M Exercise | 2023-06-30 | 2023-07-05 | 75,000 | — | $0 | 141,302 | SEC↗ |
| Gharib Samir M. | President & CFO | F Tax w/h | 2023-06-30 | 2023-07-05 | 25,936 | $2.15 | $55.8K | 115,366 | SEC↗ |
| Szwarcberg Javier B. | Chief Executive Officer | A Award | 2023-06-30 | 2023-07-05 | 20,000 | $0.98 | $19.6K | 34,705 | SEC↗ |
| Charlton Ralph William III | Chief Medical Officer | A Award | 2023-06-30 | 2023-07-05 | 12,378 | $0.98 | $12.1K | 25,242 | SEC↗ |
| Barretto-Ko Percival | Director | A Award deriv | 2023-05-25 | 2023-05-26 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Aynechi Tiba | Director | A Award deriv | 2023-05-25 | 2023-05-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| GREY MICHAEL G | Executive Chairman | A Award deriv | 2023-05-25 | 2023-05-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Muralidhar Bali | Director | A Award deriv | 2023-05-25 | 2023-05-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| O'Donnell Niall | Director | A Award deriv | 2023-05-25 | 2023-05-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SIMPSON CAMILLA V | Director | A Award deriv | 2023-05-25 | 2023-05-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SPIEGELMAN DANIEL K | Director | A Award deriv | 2023-05-25 | 2023-05-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Ways Kirk | Director | A Award deriv | 2023-05-25 | 2023-05-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| O'Donnell Niall | Director | P Buy deriv | 2023-02-16 | 2023-05-16 | 472,800 | — | $0 | 472,800 | SEC↗ |
| O'Donnell Niall | Director | P Buy | 2023-02-16 | 2023-05-16 | 630,400 | $3.17 | $2.00M | 1,326,305 | SEC↗ |
| Novo Holdings A/S | 10% Owner | P Buy deriv | 2023-02-16 | 2023-02-21 | 1,656,000 | — | $0 | 1,656,000 | SEC↗ |
| Novo Holdings A/S | 10% Owner | P Buy | 2023-02-16 | 2023-02-21 | 2,208,000 | $3.17 | $7.00M | 6,722,336 | SEC↗ |
| Gharib Samir M. | President & CFO | M Exercise deriv | 2023-01-03 | 2023-01-05 | 37,500 | — | $0 | 225,000 | SEC↗ |
| Gharib Samir M. | President & CFO | F Tax w/h | 2023-01-03 | 2023-01-05 | 15,293 | $1.15 | $17.6K | 55,818 | SEC↗ |
| Gharib Samir M. | President & CFO | M Exercise | 2023-01-03 | 2023-01-05 | 37,500 | — | $0 | 71,111 | SEC↗ |
| Gharib Samir M. | President & CFO | A Award | 2022-12-30 | 2023-01-05 | 1 | $0.93 | $1 | 33,611 | SEC↗ |
| Szwarcberg Javier B. | Chief Executive Officer | A Award | 2022-12-30 | 2023-01-05 | 14,705 | $0.93 | $13.7K | 14,705 | SEC↗ |
| Charlton Ralph William III | Chief Medical Officer | A Award | 2022-12-30 | 2023-01-05 | 12,864 | $0.93 | $12.0K | 12,864 | SEC↗ |
| Szwarcberg Javier B. | Chief Executive Officer | A Award deriv | 2022-12-05 | 2022-12-07 | 444,000 | — | $0 | 444,000 | SEC↗ |
| Gharib Samir M. | President & CFO | A Award deriv | 2022-12-05 | 2022-12-07 | 149,000 | — | $0 | 149,000 | SEC↗ |
| Charlton Ralph William III | Chief Medical Officer | A Award deriv | 2022-12-05 | 2022-12-07 | 127,000 | — | $0 | 127,000 | SEC↗ |
| Gharib Samir M. | President & CFO | M Exercise deriv | 2022-06-30 | 2022-07-05 | 37,500 | — | $0 | 262,500 | SEC↗ |
| Gharib Samir M. | President & CFO | M Exercise | 2022-06-30 | 2022-07-05 | 37,500 | — | $0 | 41,132 | SEC↗ |
| Gharib Samir M. | President & CFO | A Award | 2022-06-30 | 2022-07-05 | 5,446 | $1.48 | $8.1K | 46,578 | SEC↗ |
| Gharib Samir M. | President & CFO | F Tax w/h | 2022-06-30 | 2022-07-05 | 12,968 | $1.74 | $22.6K | 33,610 | SEC↗ |
| SIMPSON CAMILLA V | Director | A Award deriv | 2022-05-25 | 2022-05-27 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Chaya Moghrabi Dina | Director | A Award deriv | 2022-05-25 | 2022-05-27 | 22,500 | — | $0 | 22,500 | SEC↗ |
| GREY MICHAEL G | Executive Chairman | A Award deriv | 2022-05-25 | 2022-05-27 | 22,500 | — | $0 | 22,500 | SEC↗ |
| SPIEGELMAN DANIEL K | Director | A Award deriv | 2022-05-25 | 2022-05-27 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Ways Kirk | Director | A Award deriv | 2022-05-25 | 2022-05-27 | 20,625 | — | $0 | 20,625 | SEC↗ |
| Muralidhar Bali | Director | A Award deriv | 2022-05-25 | 2022-05-27 | 22,500 | — | $0 | 22,500 | SEC↗ |
| O'Donnell Niall | Director | A Award deriv | 2022-05-25 | 2022-05-27 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Aynechi Tiba | Director | A Award deriv | 2022-05-25 | 2022-05-27 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Charlton Ralph William III | Chief Medical Officer | A Award deriv | 2022-04-01 | 2022-04-01 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Gharib Samir M. | President & CFO | A Award deriv | 2022-01-03 | 2022-01-05 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Szwarcberg Javier B. | Chief Executive Officer | A Award deriv | 2022-01-03 | 2022-01-10 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Szwarcberg Javier B. | Chief Executive Officer | A Award deriv | 2022-01-03 | 2022-01-10 | 750,000 | — | $0 | 750,000 | SEC↗ |
| Gharib Samir M. | President & CFO | J Other | 2021-12-31 | 2022-01-05 | 2,220 | $3.79 | $8.4K | 4,632 | SEC↗ |
| Dias Subaweerage | Chief Medical Officer | A Award deriv | 2021-12-16 | 2021-12-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Dias Subaweerage | Chief Medical Officer | A Award deriv | 2021-12-16 | 2021-12-20 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Gharib Samir M. | Chief Financial Officer | A Award deriv | 2021-12-16 | 2021-12-20 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Gharib Samir M. | Chief Financial Officer | A Award deriv | 2021-12-16 | 2021-12-20 | 145,000 | — | $0 | 145,000 | SEC↗ |
| GREY MICHAEL G | Executive Chairman | A Award deriv | 2021-12-16 | 2021-12-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Gharib Samir M. | Chief Financial Officer | J Other | 2021-06-30 | 2021-07-06 | 1,412 | $9.53 | $13.5K | 1,412 | SEC↗ |
| KING RICHARD | Chief Executive Officer | J Other | 2021-06-30 | 2021-07-06 | 2,230 | $9.53 | $21.3K | 2,230 | SEC↗ |
| Ways Kirk | Director | A Award deriv | 2021-06-23 | 2021-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GREY MICHAEL G | Executive Chairman | A Award deriv | 2021-05-20 | 2021-05-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Chaya Moghrabi Dina | Director | A Award deriv | 2021-05-20 | 2021-05-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Muralidhar Bali | Director | A Award deriv | 2021-05-20 | 2021-05-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| O'Donnell Niall | Director | A Award deriv | 2021-05-20 | 2021-05-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SIMPSON CAMILLA V | Director | A Award deriv | 2021-05-20 | 2021-05-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SIMPSON CAMILLA V | Director | M Exercise deriv | 2021-05-20 | 2021-05-21 | 334 | — | $0 | 1,673 | SEC↗ |
| SPIEGELMAN DANIEL K | Director | A Award deriv | 2021-05-20 | 2021-05-21 | 6,667 | — | $0 | 6,667 | SEC↗ |
| SIMPSON CAMILLA V | Director | M Exercise | 2021-05-20 | 2021-05-21 | 334 | $0.85 | $284 | 334 | SEC↗ |
| SIMPSON CAMILLA V | Director | S Sale | 2021-05-20 | 2021-05-21 | 334 | $15.29 | $5.1K | 0 | SEC↗ |
| Novo Holdings A/S | 10% Owner | S Sale | 2021-05-19 | 2021-05-21 | 475,000 | $13.90 | $6.60M | 4,514,336 | SEC↗ |
| SIMPSON CAMILLA V | Director | M Exercise deriv | 2021-04-30 | 2021-05-04 | 14,045 | — | $0 | 2,007 | SEC↗ |
| SIMPSON CAMILLA V | Director | S Sale | 2021-04-30 | 2021-05-04 | 14,045 | $16.14 | $226.7K | 0 | SEC↗ |
| SIMPSON CAMILLA V | Director | M Exercise | 2021-04-30 | 2021-05-04 | 14,045 | $0.85 | $11.9K | 14,045 | SEC↗ |
| Dias Subaweerage | Chief Medical Officer | A Award deriv | 2021-01-28 | 2021-01-29 | 27,500 | — | $0 | 27,500 | SEC↗ |
| Gharib Samir M. | Chief Financial Officer | A Award deriv | 2021-01-28 | 2021-01-29 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Chief Executive Officer | A Award deriv | 2021-01-28 | 2021-01-29 | 155,000 | — | $0 | 155,000 | SEC↗ | |
| HANSSON JONAS | Director | C Conversion deriv | 2020-10-14 | 2020-10-16 | 11,666,666 | — | $0 | 0 | SEC↗ |
| HealthCap VIII, L.P. | Other | C Conversion deriv | 2020-10-14 | 2020-10-16 | 11,666,666 | — | $0 | 0 | SEC↗ |
| Chaya Moghrabi Dina | Director | C Conversion deriv | 2020-10-14 | 2020-10-16 | 12,500,000 | — | $0 | 0 | SEC↗ |
| Omega Fund VI GP Manager, Ltd. | 10% Owner | C Conversion deriv | 2020-10-14 | 2020-10-16 | 12,500,000 | — | $0 | 0 | SEC↗ |
| O'Donnell Niall | Director | C Conversion deriv | 2020-10-14 | 2020-10-16 | 2,916,664 | — | $0 | 0 | SEC↗ |
| Muralidhar Bali | Director | C Conversion deriv | 2020-10-14 | 2020-10-16 | 10,416,666 | — | $0 | 0 | SEC↗ |
| RiverVest Venture Fund III, L. | 10% Owner | C Conversion deriv | 2020-10-14 | 2020-10-16 | 5,416,666 | — | $0 | 0 | SEC↗ |
| RiverVest Venture Fund III, L. | 10% Owner | C Conversion deriv | 2020-10-14 | 2020-10-16 | 7,000,000 | — | $0 | 0 | SEC↗ |
| Novo Holdings A/S | 10% Owner | C Conversion deriv | 2020-10-14 | 2020-10-16 | 10,000,000 | — | $0 | 0 | SEC↗ |
| Novo Holdings A/S | 10% Owner | C Conversion deriv | 2020-10-14 | 2020-10-16 | 21,000,000 | — | $0 | 0 | SEC↗ |
| HANSSON JONAS | Director | P Buy | 2020-10-14 | 2020-10-16 | 250,000 | $15.00 | $3.75M | 2,033,621 | SEC↗ |
| HANSSON JONAS | Director | C Conversion | 2020-10-14 | 2020-10-16 | 1,783,621 | — | $0 | 1,783,621 | SEC↗ |
| HealthCap VIII, L.P. | Other | C Conversion | 2020-10-14 | 2020-10-16 | 1,783,621 | — | $0 | 1,783,621 | SEC↗ |
| HealthCap VIII, L.P. | Other | P Buy | 2020-10-14 | 2020-10-16 | 250,000 | $15.00 | $3.75M | 2,033,621 | SEC↗ |
| Chaya Moghrabi Dina | Director | P Buy | 2020-10-14 | 2020-10-16 | 250,000 | $15.00 | $3.75M | 2,161,022 | SEC↗ |
| Chaya Moghrabi Dina | Director | C Conversion | 2020-10-14 | 2020-10-16 | 1,911,022 | — | $0 | 1,911,022 | SEC↗ |
| Omega Fund VI GP Manager, Ltd. | 10% Owner | P Buy | 2020-10-14 | 2020-10-16 | 250,000 | $15.00 | $3.75M | 2,161,022 | SEC↗ |
| Omega Fund VI GP Manager, Ltd. | 10% Owner | C Conversion | 2020-10-14 | 2020-10-16 | 1,911,022 | — | $0 | 1,911,022 | SEC↗ |
| O'Donnell Niall | Director | C Conversion | 2020-10-14 | 2020-10-16 | 445,905 | — | $0 | 445,905 | SEC↗ |
| O'Donnell Niall | Director | P Buy | 2020-10-14 | 2020-10-16 | 250,000 | $15.00 | $3.75M | 695,905 | SEC↗ |
| Muralidhar Bali | Director | P Buy | 2020-10-14 | 2020-10-16 | 200,000 | $15.00 | $3.00M | 1,792,518 | SEC↗ |
| Muralidhar Bali | Director | C Conversion | 2020-10-14 | 2020-10-16 | 1,592,518 | — | $0 | 1,592,518 | SEC↗ |
| RiverVest Venture Fund III, L. | 10% Owner | C Conversion | 2020-10-14 | 2020-10-16 | 828,109 | — | $0 | 1,898,281 | SEC↗ |
| RiverVest Venture Fund III, L. | 10% Owner | P Buy | 2020-10-14 | 2020-10-16 | 250,000 | $15.00 | $3.75M | 2,148,281 | SEC↗ |
| RiverVest Venture Fund III, L. | 10% Owner | C Conversion | 2020-10-14 | 2020-10-16 | 1,070,172 | — | $0 | 1,070,172 | SEC↗ |
| Novo Holdings A/S | 10% Owner | C Conversion | 2020-10-14 | 2020-10-16 | 4,739,336 | — | $0 | 4,739,336 | SEC↗ |
| Novo Holdings A/S | 10% Owner | P Buy | 2020-10-14 | 2020-10-16 | 250,000 | $15.00 | $3.75M | 4,989,336 | SEC↗ |